GABA
Allosteric Regulation
/ drug effects
Animals
Benzodiazepines
/ chemistry
Binding Sites
/ drug effects
Drug Design
GABA-A Receptor Antagonists
/ chemistry
Humans
Ligands
Models, Molecular
Protein Domains
/ drug effects
Quinolones
/ chemistry
Receptors, GABA-A
/ chemistry
gamma-Aminobutyric Acid
/ metabolism
GABAA
benzodiazepines (BZ)
binding sites
etomidate
receptors
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
03 Jan 2020
03 Jan 2020
Historique:
received:
29
11
2019
revised:
20
12
2019
accepted:
26
12
2019
entrez:
18
1
2020
pubmed:
18
1
2020
medline:
9
9
2020
Statut:
epublish
Résumé
Many allosteric binding sites that modulate gamma aminobutyric acid (GABA) effects have been described in heteropentameric GABA type A (GABA
Identifiants
pubmed: 31947863
pii: ijms21010334
doi: 10.3390/ijms21010334
pmc: PMC6982053
pii:
doi:
Substances chimiques
GABA-A Receptor Antagonists
0
Ligands
0
Quinolones
0
Receptors, GABA-A
0
Benzodiazepines
12794-10-4
gamma-Aminobutyric Acid
56-12-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Austrian Science Fund FWF
ID : W 1232
Pays : Austria
Organisme : Austrian Science Fund
ID : W1232
Références
Adv Pharmacol. 2015;72:53-96
pubmed: 25600367
Mol Pharmacol. 1995 Dec;48(6):965-9
pubmed: 8848011
J Mol Biol. 1997 Apr 4;267(3):727-48
pubmed: 9126849
Phys Rev B Condens Matter. 1986 Jun 15;33(12):8822-8824
pubmed: 9938299
J Neurosci. 2011 Jan 19;31(3):870-7
pubmed: 21248110
Neuropharmacology. 2018 Jul 1;136(Pt A):10-22
pubmed: 29407219
Trends Pharmacol Sci. 1997 Nov;18(11):425-9
pubmed: 9426470
Br J Pharmacol. 2013 May;169(2):371-83
pubmed: 23472852
Br J Pharmacol. 1999 Jul;127(5):1231-9
pubmed: 10455270
Anesthesiology. 2009 Oct;111(4):774-84
pubmed: 19741491
Nature. 2018 Jul;559(7712):67-72
pubmed: 29950725
Biochem Pharmacol. 1984 Dec 15;33(24):4033-8
pubmed: 6095867
Sci Rep. 2017 Jul 18;7(1):5674
pubmed: 28720884
Br J Pharmacol. 2012 Feb;165(4):965-77
pubmed: 21806603
Nature. 2019 Jan;565(7740):454-459
pubmed: 30602790
J Biol Chem. 2002 Nov 29;277(48):46020-5
pubmed: 12324466
Adv Pharmacol. 2015;72:189-200
pubmed: 25600371
Planta Med. 2003 Feb;69(2):113-7
pubmed: 12624814
Br J Pharmacol. 2000 Oct;131(4):843-50
pubmed: 11030736
Pharmacol Rev. 2018 Oct;70(4):836-878
pubmed: 30275042
Nat Neurosci. 2000 Dec;3(12):1274-81
pubmed: 11100148
Curr Pharm Des. 2015;21(34):4943-59
pubmed: 26365137
J Neurochem. 2016 Sep;138(5):722-30
pubmed: 27319298
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):11031-6
pubmed: 9380754
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4569-73
pubmed: 8183949
Front Mol Neurosci. 2016 Jun 16;9:44
pubmed: 27378845
Eur J Med Chem. 2019 Oct 15;180:340-349
pubmed: 31325782
Nat Commun. 2013;4:1875
pubmed: 23695669
Nat Chem Biol. 2012 Mar 25;8(5):455-64
pubmed: 22446838
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7769-74
pubmed: 15136735
Biochemistry. 2012 Jan 31;51(4):836-47
pubmed: 22243422
Neuron. 1994 Apr;12(4):775-82
pubmed: 8161449
J Biol Chem. 2001 Sep 28;276(39):36275-80
pubmed: 11466317
J Med Chem. 2002 Jun 20;45(13):2824-31
pubmed: 12061884
Br J Pharmacol. 2013 May;169(2):384-99
pubmed: 23472935
Neuropharmacology. 2016 Jun;105:207-214
pubmed: 26767954
Mol Pharmacol. 2002 Apr;61(4):861-9
pubmed: 11901225
Mol Pharmacol. 2001 Jun;59(6):1470-7
pubmed: 11353808
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
pubmed: 4202581
Phys Rev Lett. 1996 Oct 28;77(18):3865-3868
pubmed: 10062328
Eur J Med Chem. 2019 Jun 1;171:434-461
pubmed: 30928713
Br J Pharmacol. 2004 Jul;142(5):811-20
pubmed: 15231642
ACS Chem Biol. 2018 Aug 17;13(8):2040-2047
pubmed: 29989390